5 Free Dividend Stocks for 2022
Could these top payout stocks be part of the greatest wealth-creating tool in history?
Learn More.
Catherine M. Szyman, insider at Edwards Lifesciences
Catherine M. Szyman Insider Alerts

Get notified the next time Catherine M. Szyman buys or sells Edwards Lifesciences stock. Enter your email address below to get our daily insider buying and selling report.

Catherine M. Szyman Insider Information

Catherine "Katie" Szyman is the corporate vice president, critical care at Edwards Lifesciences Corp., a role she has held since 2015. 

Prior to Edwards, Szyman spent over 20 years at Medtronic, where she held the role of SVP and president of its global diabetes business from 2009 to 2014, overseeing research, development, sales, marketing and operations for its insulin infusion pumps and continuous glucose monitoring systems.

Additionally, Szyman held multiple leadership positions at Medtronic, including SVP of corporate strategy and business development, general manager of endovascular innovations and VP of finance for the cardiovascular business. She currently sits on the boards of Endotronix, Octane OC, Outset Medical, the American Heart Association of Orange County, Opus School of Business and Inari Medical, and she previously served on the boards of Inspire Medical Systems, Tornier, and the California Healthcare Institute.

Szyman earned her bachelor’s degree from the University of St. Thomas in St. Paul, Minnesota, and she holds an M.B.A. from Harvard Business School.

What is Catherine M. Szyman's net worth?

The estimated net worth of Catherine M. Szyman is at least $4.97 million as of August 2nd, 2021. Ms. Szyman owns 42,759 shares of Edwards Lifesciences stock worth more than $4,966,885 as of January 20th. This net worth approximation does not reflect any other assets that Ms. Szyman may own. Learn More.

How do I contact Catherine M. Szyman?

The corporate mailing address for Ms. Szyman and other Edwards Lifesciences executives is ONE EDWARDS WAY, IRVINE CA, 92614. Edwards Lifesciences can also be reached via phone at (949) 250-2500 and via email at [email protected]

Has Catherine M. Szyman been buying or selling shares of Edwards Lifesciences?

Within the last three months, Catherine M. Szyman has sold $1,195,300.00 in shares of Edwards Lifesciences stock. Most recently, Catherine M. Szyman sold 10,000 shares of the business's stock in a transaction on Friday, January 14th. The shares were sold at an average price of $119.53, for a transaction totalling $1,195,300.00.

Who are Edwards Lifesciences' active insiders?

Edwards Lifesciences' insider roster includes Donald Bobo, Jr (VP), Leslie Heisz (Director), Jean-Luc Lemercier (VP), Michael Mussallem (CEO), Catherine Szyman (VP), Nicholas Valeriani (Director), Huimin Wang (VP), and Larry Wood (VP).

Are insiders buying or selling shares of Edwards Lifesciences?

In the last year, Edwards Lifesciences insiders bought shares 1 times. They purchased a total of 1,500 shares worth more than $168,345.00. In the last year, insiders at the medical research company sold shares 50 times. They sold a total of 822,473 shares worth more than $82,027,316.16. The most recent insider tranaction occured on January, 14th when VP Catherine M Szyman sold 10,000 shares worth more than $1,195,300.00. Insiders at Edwards Lifesciences own 1.4 % of the company.

Information on this page was last updated on 1/14/2022.

Catherine M. Szyman Insider Trading History at Edwards Lifesciences

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/14/2022Sell10,000$119.53$1,195,300.00View SEC Filing Icon  
12/17/2021Sell10,000$121.24$1,212,400.00View SEC Filing Icon  
11/18/2021Sell10,000$117.79$1,177,900.00View SEC Filing Icon  
10/18/2021Sell9,741$110.41$1,075,503.81View SEC Filing Icon  
8/2/2021Sell15,000$113.53$1,702,950.0042,759View SEC Filing Icon  
5/28/2021Sell2,061$95.29$196,392.6927,705View SEC Filing Icon  
5/25/2021Sell4,665$96.09$448,259.8529,766View SEC Filing Icon  
4/22/2021Sell3,389$94.40$319,921.6030,355View SEC Filing Icon  
2/16/2021Sell3,389$88.20$298,909.8030,135View SEC Filing Icon  
10/29/2020Sell20,355$73.24$1,490,800.2047,101View SEC Filing Icon  
8/13/2020Sell2,249$78.24$175,961.7626,746View SEC Filing Icon  
7/14/2020Sell2,249$67.66$152,167.3428,995View SEC Filing Icon  
6/11/2020Sell2,249$68.06$153,066.9434,564View SEC Filing Icon  
5/13/2020Sell750$216.93$162,697.5018,318View SEC Filing Icon  
4/16/2020Sell1,116$216.91$242,071.5614,755View SEC Filing Icon  
3/23/2020Sell1,116$162.95$181,852.2015,773View SEC Filing Icon  
2/18/2020Sell2,500$228.57$571,425.0019,389View SEC Filing Icon  
12/16/2019Sell2,500$234.27$585,675.0019,605View SEC Filing Icon  
11/15/2019Sell2,500$242.14$605,350.0019,605View SEC Filing Icon  
10/25/2019Sell2,500$227.19$567,975.0019,605View SEC Filing Icon  
9/19/2019Sell2,500$216.71$541,775.0020,138View SEC Filing Icon  
8/15/2019Sell372$214.53$79,805.1618,010View SEC Filing Icon  
7/15/2019Sell1,152$191.70$220,838.4019,162View SEC Filing Icon  
6/14/2019Sell1,474$184.55$272,026.7020,250View SEC Filing Icon  
5/15/2019Sell1,474$177.92$262,254.0821,396View SEC Filing Icon  
4/15/2019Sell1,474$192.00$283,008.0021,132View SEC Filing Icon  
3/15/2019Sell1,146$179.10$205,248.6022,229View SEC Filing Icon  
2/21/2019Sell1,474$176.34$259,925.1615,905View SEC Filing Icon  
1/15/2019Sell700$155.00$108,500.0024,482View SEC Filing Icon  
10/15/2018Sell700$142.64$99,848.0027,772View SEC Filing Icon  
5/24/2018Sell9,815$139.39$1,368,112.8520,012View SEC Filing Icon  
See Full Table

Catherine M. Szyman Buying and Selling Activity at Edwards Lifesciences

This chart shows Catherine M Szyman's buying and selling at Edwards Lifesciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Edwards Lifesciences Company Overview

Edwards Lifesciences logo
Edwards Lifesciences Corp. engages in the patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into three areas: Transcatheter Heart Valves, Surgical Structural Heart, and Critical Care. The Transcatheter Heart Valves portfolio includes technologies designed to treat heart valve disease using catheter-based approaches as opposed to open surgical techniques. The Surgical Structural Heart portfolio includes tissue heart valves and heart valve repair products for the surgical replacement or repair of a patient's heart valve. The Critical Care portfolio products through hemodynamic monitoring system measures a patient's heart function and fluid status in surgical and intensive care settings. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.
Read More

Today's Range

Now: $116.16
Low: $115.97
High: $118.15

50 Day Range

MA: $119.51
Low: $107.31
High: $130.68

2 Week Range

Now: $116.16
Low: $78.44
High: $131.73


2,236,775 shs

Average Volume

2,205,554 shs

Market Capitalization

$72.52 billion

P/E Ratio


Dividend Yield



5 Free Dividend Stocks for 2022
Could these top payout stocks be part of the greatest wealth-creating tool in history?
Learn More.